Spectrum Pharmaceuticals Inc (SPPI):企業の財務・戦略的SWOT分析

◆英語タイトル:Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15770
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Spectrum Pharmaceuticals Inc (SPPI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection); Zevalin (ibritumomab tiuxetan); Marqibo (vincristine sulfate liposome injection), Beleodaq (belinostat) and Evomela (Captisol-Enabled Melphalan). It also has drugs in mid-to-late stage development, namely, Rolontis (eflapegrastim) for chemotherapy-induced neutropenia; Qapzola (apaziquone) for Intravesical Instillation; and Poziotinib for the treatment of various types of cancers. The company markets its products through direct sales force in the US and through distributors in Europe. Spectrum is headquartered in Henderson, Nevada, the US.

Spectrum Pharmaceuticals Inc Key Recent Developments

Mar 13,2019 Spectrum Pharmaceuticals to Present Corporate Update at the Oppenheimer 29th Annual Healthcare Conference on March 20
Feb 28,2019 Spectrum Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results and pipeline update
Jan 18,2019 Acrotech Biopharma to buy seven drugs from Spectrum for $300m
Dec 06,2018 Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS (eflapegrastim) at the 2018 SABCS Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Spectrum Pharmaceuticals Inc – Key Facts
Spectrum Pharmaceuticals Inc – Key Employees
Spectrum Pharmaceuticals Inc – Key Employee Biographies
Spectrum Pharmaceuticals Inc – Major Products and Services
Spectrum Pharmaceuticals Inc – History
Spectrum Pharmaceuticals Inc – Company Statement
Spectrum Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Spectrum Pharmaceuticals Inc – Business Description
Product Category: Beleodaq
Overview
Performance
Product Category: Evomela
Overview
Performance
Product Category: Folotyn
Overview
Performance
Product Category: Fusilev
Performance
Product Category: Khapzory
Overview
Performance
Product Category: Marqibo
Overview
Performance
Product Category: Zevalin
Overview
Performance
Product Category: License fees and service revenue
Performance
Product Category: Product Sales
Performance
Geographical Segment: International
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Spectrum Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Spectrum Pharmaceuticals Inc – Strengths
Spectrum Pharmaceuticals Inc – Weaknesses
Spectrum Pharmaceuticals Inc – Opportunities
Spectrum Pharmaceuticals Inc – Threats
Spectrum Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Spectrum Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 13, 2019: Spectrum Pharmaceuticals to Present Corporate Update at the Oppenheimer 29th Annual Healthcare Conference on March 20
Feb 28, 2019: Spectrum Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results and pipeline update
Jan 18, 2019: Acrotech Biopharma to buy seven drugs from Spectrum for $300m
Dec 06, 2018: Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS (eflapegrastim) at the 2018 SABCS Annual Meeting
Nov 13, 2018: Spectrum Pharmaceuticals names Dr. Jeffrey Vacirca to its Board of Directors
Nov 08, 2018: Spectrum Pharmaceuticals reports third quarter 2018 pipeline update and financial results
Nov 06, 2018: Haymi Behar to Head SPI’s International Marketing Operations
Nov 01, 2018: Spectrum Pharmaceuticals Announces Third Quarter 2018 Financial Results Teleconference and Webcast
Oct 18, 2018: Spectrum Pharmaceuticals names Dr. Francois Lebel as chief medical officer
Oct 18, 2018: Spectrum pharmaceuticals announces Dr. Francois Lebel as chief medical officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Spectrum Pharmaceuticals Inc, Key Facts
Spectrum Pharmaceuticals Inc, Key Employees
Spectrum Pharmaceuticals Inc, Key Employee Biographies
Spectrum Pharmaceuticals Inc, Major Products and Services
Spectrum Pharmaceuticals Inc, History
Spectrum Pharmaceuticals Inc, Other Locations
Spectrum Pharmaceuticals Inc, Subsidiaries
Spectrum Pharmaceuticals Inc, Joint Venture
Spectrum Pharmaceuticals Inc, Key Competitors
Spectrum Pharmaceuticals Inc, Ratios based on current share price
Spectrum Pharmaceuticals Inc, Annual Ratios
Spectrum Pharmaceuticals Inc, Annual Ratios (Cont...1)
Spectrum Pharmaceuticals Inc, Interim Ratios
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Spectrum Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Spectrum Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Spectrum Pharmaceuticals Inc, Ratio Charts
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Spectrum Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Spectrum Pharmaceuticals Inc (SPPI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clovis Oncology Inc (CLVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • ViaCyte Inc-製薬・医療分野:企業M&A・提携分析
    Summary ViaCyte Inc (ViaCyte), formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline product portfolio includes VC-01, which is being developed as a therapy for T1D patients who h …
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kraton Polymers LLC:企業の戦略的SWOT分析
    Kraton Polymers LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Viridian Group Investments Ltd:電力:M&Aディール及び事業提携情報
    Summary Viridian Group Investments Limited (Viridian), a subsidiary of Viridian Group Holdings Limited, is an independent energy company. Through subsidiaries, it generates and supplies electricity in Northern Ireland and the Republic of Ireland (RoI). It supplies natural gas to business customers i …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務情報
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Matsuda Sangyo Co Ltd (7456):企業の財務・戦略的SWOT分析
    Matsuda Sangyo Co Ltd (7456) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • NeuroSearch AS (NEUR)-製薬・医療分野:企業M&A・提携分析
    Summary NeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patien …
  • ComOps Limited (COM):企業の財務・戦略的SWOT分析
    ComOps Limited (COM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Waterman Group Plc (WTM):企業の財務・戦略的SWOT分析
    Summary Waterman Group Plc (Waterman), formerly Waterman Partnership Holdings Plc, a subsidiary of CTI Engineering Co Ltd, is an engineering and environmental consultancy service provider that offers services for property, infrastructure, environment and energy markets. The company provides services …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Gammon Infrastructure Projects Ltd (GAMMNINFRA)-エネルギー分野:企業M&A・提携分析
    Summary Gammon Infrastructure Projects Limited (GIPL) is an infrastructure project development company. It undertakes projects on a public private partnership basis (PPP) across various sectors including hydro power, roads and expressways, ports, urban infrastructure, airports, special economic zone …
  • SandRidge Energy Inc (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • ICBC Standard Bank Plc:企業の戦略・SWOT・財務情報
    ICBC Standard Bank Plc - Strategy, SWOT and Corporate Finance Report Summary ICBC Standard Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MIS Implants Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers products such as superstructures, dental implants, tools and kits, and solutions for oral restoration and health, among others. It …
  • Biosense Webster Inc-医療機器分野:企業M&A・提携分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson is a medical device company that offers cardiac arrhythmias products. The company designs, manufactures and markets products for diagnosis and treatment of cardiac arrhythmias. Its products comprise ablation catheters …
  • Softship AG:企業の戦略的SWOT分析
    Softship AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Banco Santander SA:戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆